Jennifer Seminerio, MD

Dr. Seminerio predicts how the future landscape will change for intravenous and subcutaneous biologics.

A gastroenterologist discusses the role of biosimilars in her clinical practice.

An expert gastroenterologist dissects a study that analyzed patient experience with intravenous and subcutaneous biological therapies.

Key topics in cost of intravenous and subcutaneous biologics are discussed by Dr Seminerio.

An expert clinician expands on efficacy results seen in a study comparing intravenous and subcutaneous biologics.

Dr Seminerio highlights the differences in billing between intravenous and subcutaneous biologics.

A gastroenterologist speaks about patient adherence when utilizing intravenous biologics.

Dr. Seminerio talks about how she positions intravenous and subcutaneous biologics and which patients benefit from each route of administration.

A leading gastroenterologist highlights her initial thoughts about subcutaneous biologics.

Dr. Seminerio uncovers what excited her about IV biologics when they first came to market.

An expert gastroenterologist highlights what her experience has been like with subcutaneous biologics.

Dr. Jennifer Seminerio discusses what what her overall perspective with intravenous biologics in gastrointestinal diseases